Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue
+3.07%
EPS
−13.5%
Free cash flow
+29.8%
Total debt
−7.50%

Quarter to September 2026, against a year earlier

106.64 0.21 −0.20%
Market cap
$20.4B
P/E
26.9×
Fwd P/E
18.9×
Dividend yield
0.90%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100

Zimmer Biomet Holdings, Inc. (ZBH) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by products and services, and margins
Knees 3,322 40.36%
S.E.T 2,150 26.12%
Hips 2,094 25.43%
Technology & Data, Bone Cement and Surgical 666 8.09%
Gross margin 69.71%
Operating margin 13.34%
Pre-tax margin 10.09%

Revenue by product or service $m

Line FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016
Knees 3,322 3,174 3,038 2,778 2,648 2,378 2,781 2,774 2,734 2,751
S.E.T 2,150 1,866 1,753 1,697 1,728 1,526 1,653 1,401 1,702 1,639
Hips 2,094 1,999 1,967 1,895 1,856 1,751 1,932 1,919 1,872 1,862
Technology & Data, Bone Cement and Surgical 666 640 636 570 596 473 596 664 319 328
Dental And Spine — — — — — — 1,022 — — —
Dental Spine And C M F T — — — — — — — 1,175 — —
Spine And C M F — — — — — — — — 758 661
Dental — — — — — — — — 419 428
Revenue 8,232 7,679 7,394 6,940 6,827 6,128 7,982 7,933 7,803 7,668

Gross profit by product or service $m, and margin

Revenue by region $m

Line FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
US 4,764 4,439 4,289 4,012 3,854 3,508
International 3,468 3,240 3,105 2,928 2,973 2,620
Also reported: a second breakdown of the same revenue
Americas 5,145 4,795 4,624 4,296 4,102 3,700
EMEA 1,829 1,691 1,592 1,457 1,477 1,237
Asia Pacific 1,258 1,193 1,178 1,188 1,248 1,191
Revenue 8,232 7,679 7,394 6,940 6,827 6,128

Operating income by segment $m, and margin

Operating figures as reported in each quarter’s results release or filing

Figure Quarter Latest A year before Change
Remaining performance obligations Q4 FY2025 $0.00 $0.00 —

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.